Seeking genetic determinants of selected metabolic disorders in women aged 45–60

• Main Authors: Małgorzata Szkup, Jacek Brodowski, Anna Jurczak, Marzanna Stanisławska, Elżbieta Grochans
• Format: Article
• Language: English
• Published: Institute of Rural Health 2020-09-01
• Series: Annals of Agricultural and Environmental Medicine
• Subjects: genes; metabolic syndrome x; ppar gamma
• Online Access: http://www.aaem.pl/Seeking-genetic-determinants-of-selected-metabolic-disorders-in-women-aged-45-60,112579,0,2.html

Introduction and objective The biochemical and anthropometric consequences of metabolic disorders exert an enormous effect on the functioning of people worldwide. The aim of this study is to assess relationships between biochemical and anthropometric parameters associated with metabolic syndrome, and the presence of the PPAR-γ rs1801282, the FTO rs9939609, and the MC4R rs17782313 polymorphisms in women aged 45–60. Material and methods The study included 425 women, aged 45–59 years, from the general population of the West Pomeranian Province in north-west Poland. The research procedure involved a structured interview, anthropometric and blood pressure measurements, biochemical analysis of serum, and genetic analysis. Results The carriers of the A/A genotype of the FTO polymorphism had higher LDL levels than their counterparts with the T/T genotype (p = 0.01). The carriers of the T/T genotype of the MC4R polymorphism had lower non-HDL levels than those with the C/C and C/T genotypes (p = 0.019). Weight was related to the C/C and the C/G + G/G genotypes of the PPAR-γ gene polymorphism (p = 0.046). The model of inheritance for the MC4R polymorphism had a significant effect on TG (p = 0.039) and non-HDL (p = 0.05) levels. Conclusions The genotypes analyzed in the study had only a slight direct effect on the biochemical and anthropometric abnormalities typical of metabolic disorders. Nonetheless, the risk alleles (A allele of the FTO rs9939609 and the C allele of the MC4R rs17782313) were found to be related to lipid metabolism disorders in 45–60-year-old women.